Munch-Petersen, H. D., Asmar, F., Dimopoulos, K., Areškevičiūtė, A., Brown, P., Girkov, M. S., . . . Grønbæk, K. (2016). TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy. Acta Neuropathol Commun.
Chicago Style CitationMunch-Petersen, Helga D., et al. "TP53 Hotspot Mutations Are Predictive of Survival in Primary Central Nervous System Lymphoma Patients Treated With Combination Chemotherapy." Acta Neuropathol Commun 2016.
Cita MLAMunch-Petersen, Helga D., et al. "TP53 Hotspot Mutations Are Predictive of Survival in Primary Central Nervous System Lymphoma Patients Treated With Combination Chemotherapy." Acta Neuropathol Commun 2016.
Atenció: Aquestes cites poden no estar 100% correctes.